Polyelectrolyte membranes based on phosphorylated-PVA/cellulose acetate for direct methanol fuel cell applications: synthesis, instrumental characterization, and performance testing.

Designing and synthesis of cost-effective and improved methanol permeable and proton conductive membranes are the main challenges for preparation of polymeric electrolyte membrane (PEM). Herein, a cost-effective PEM membrane based on phosphorylated polyvinyl alcohol (PVA)-grafted-cellulose acetate (CA) was prepared by a solution-casting technique. Water and methanol uptakes of phosphorylated PVA/CA membranes were characterized as function with the molar ratio of CA. Additionally, structure and morphology of phosphorylated PVA/CA (Ph-PVA/CA) membranes were verified by FT-IR analysis, SEM investigation. Furthermore, ion exchange capacity (IEC), proton conductivity and methanol permeation of Ph-PVA/CA membranes were examined based on the concentration of OPA basically. The results manifested a perceptible improvement in proton conductivity from 0.035 to 0.05 S/cm at 25 and 70 °C, respectively using 600 µL of OPA, and IEC of 2.1 meq/g using 400 µL of OPA at ambient temperature. On the other hand, methanol permeability (P = 1.08 × 10-10 cm2/s) was lower than Nafion 117 admirably. The optimum OPA concentration was 200 µL according to conductivity measurements (at 10% PVA, 150 µL GA, and CA 7%). Finally, prepared Ph-PVA/CA membranes exhibited enhancement in critical natures such as proton conductivity and IEC combined with its low-cost materials, which make them excellent candidate as PEM for DMFCs application.

Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs: A Case Study of Lopinavir/Ritonavir.

BACKGROUND: Lopinavir/ritonavir (LPV/r-A, Kaletra®), a fixed dose, co-formulated antiviral therapy for the treatment of HIV infection has been used worldwide for over two decades. Both active substances have low solubility in water and low membrane permeability. LPV/r-A tablets contain key excipients critical to ensuring acceptable bioavailability of lopinavir and ritonavir in humans. An established dog pharmacokinetic model demonstrated several generic LPV/r tablet formulations have significant oral bioavailability variability compared to LPV/r-A. METHODS: Analytical characterizations of LPV/r-B tablets were performed and a clinical study was conducted to assess the relative bioavailability of Kalidavir® (LPV/r-B) 400/100 mg tablets relative to Kaletra® (LPV/r-A) 400/100 mg tablets under fasting conditions. RESULTS: The presence of active substances were confirmed in LPV/r-B tablets in an apparent amorphous state at essentially the labeled amounts, and dissolution profiles were generally similar to LPV/r-A tablets. Excipients in the tablet formulation were found to be variable and deviate from the labeled composition. Lopinavir and ritonavir exposures (AUC) following LPV/r-B administration were approximately 90% and 20% lower compared to that of LPV/r-A. CONCLUSIONS: LPV/r-B was not shown to be bioequivalent to LPV/r-A.

Multifunctional cellulose nanocrystal /metal oxide hybrid, photo-degradation, antibacterial and larvicidal activities.

Cellulose nanocrystal (CNC) and ZnO/CuO nanostructure were successfully synthesized by acid hydrolysis and sol-chemical methods, respectively. For the first time, CNC was used as a host polymer for synthesis of CNC/ZnO/CuO through In-situ solution casting technique. Morphological and structural of CNC, ZnO/CuO and hybrid CNC/ZnO/CuO were investigated by TEM, SEM-EDX, FT-IR, XRD and XPS analyses. The analysis revealed that, poly-dispersed, smooth and rod like CNC with an average length of ∼ 85.4 nm, average diameter of ∼13.9 nm and surface charge of 0.01 mmol/gm. As well, irregular shapes as hexagonal, spherical and cluster or star like of ZnO/CuO were formed. EDX and XRD spectra exhibited highly purified CNC/ZnO/CuO and pointed to cellulose II crystallite form with a monoclinic structure. The results demonstrated that, 91.3 % and 99.7 % dye degradation was achieved after 40 min of irradiation due to ZnO/CuO and CNC/ZnO/CuO treatment. Moreover, the inhibition zones formed due to 100 ppm ZnO/CuO were duplicated after integrating CNC (from 7.7:10.3 mm to 14.3:20.3 mm). The hybrid nanostructure exhibit larvicidal activity against Anopheles stephensi better than CNC and ZnO/CuO nanostructures.

Modeling and optimizing Acid Orange 142 degradation in aqueous solution by non-thermal plasma.

The effects of the high voltage electrode material, initial pH of the solution, initial concentration of Fe2+, and time of plasma treatment on the efficiency of Acid Orange 142 (AO142) degradation were studied and evaluated. Furthermore, based on the Box-Behnken response surface methodology (BBD-RSM), a model between response (decolorization efficiency %) and influencing factors was proposed to estimate the interactive effects and optimize the process conditions. The proposed model was adequate with an R2 of 0.8005 which is in reasonable agreement with the R2adj of 0.9307. According to the model, the optimum conditions were steel as a high voltage electrode, an initial pH 3.0, an initial Fe2+ concentration 0.9 mM, and 20 min time of treatment to obtain a decolorization efficiency of 95.05%. In addition, the analytical results of UV-Vis, FT-IR, TOC and GC-MS indicated the degradation of the dye molecule.

Power conditioning using dynamic voltage restorers under different voltage sag types.

Voltage sags can be symmetrical or unsymmetrical depending on the causes of the sag. At the present time, one of the most common procedures for mitigating voltage sags is by the use of dynamic voltage restorers (DVRs). By definition, a DVR is a controlled voltage source inserted between the network and a sensitive load through a booster transformer injecting voltage into the network in order to correct any disturbance affecting a sensitive load voltage. In this paper, modelling of DVR for voltage correction using MatLab software is presented. The performance of the device under different voltage sag types is described, where the voltage sag types are introduced using the different types of short-circuit faults included in the environment of the MatLab/Simulink package. The robustness of the proposed device is evaluated using the common voltage sag indices, while taking into account voltage and current unbalance percentages, where maintaining the total harmonic distortion percentage of the load voltage within a specified range is desired. Finally, several simulation results are shown in order to highlight that the DVR is capable of effective correction of the voltage sag while minimizing the grid voltage unbalance and distortion, regardless of the fault type.

Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery.

PURPOSE: To provide a feasible solution to the problem of failed glaucoma surgery. The aim was to evaluate the efficacy and safety of the additional effects of a combined surgical approach. This approach augments the application of trabeculectomy with mitomycin C (MMC) by adding subconjunctival bevacizumab injection. The results were compared with those of trabeculectomy with only adjunctive MMC. METHODS: A randomized controlled prospective clinical trial included 28 eyes diagnosed with failed scarred bleb of a previous trabeculectomy. The eyes were divided into two equal groups: combined group A, "trabeculectomy with adjunctive MMC and subconjunctival bevacizumab," and control group B, "trabeculectomy with adjunctive MMC only." The main outcome results included the cumulative probability of surgical success, intraocular pressure (IOP) values, and number of IOP-lowering medications needed to achieve the target IOP. RESULTS: Group A achieved a cumulative probability of complete success of 0.769 and of qualified success of 0.231 at the end of the 24 month study period; group B achieved cumulative probabilities of 0.538 and 0.308, respectively. Group A achieved a lower mean IOP value than group B, with fewer antiglaucoma drugs at all postoperative visits, but this lower value did not reach a statistically significant level (P>0.05). There was no statistically significant difference between both groups regarding best corrected visual acuity, visual field parameters, operative and/or postoperative complications, and additional interventions. No significant adverse effects were caused by this combined approach. CONCLUSION: Bevacizumab was not found to add much to the favorable long-term outcome of conventional trabeculectomy with MMC as a solution to the problem of scarred failed bleb.

Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.

BACKGROUND: The purpose of this study was to compare the safety and efficacy of combined vitrectomy, intravitreal triamcinolone acetonide (IVTA), and bevacizumab injection with that of IVTA and bevacizumab injection and subsequent macular grid laser photocoagulation for the treatment of intractable diffuse diabetic macular edema. METHODS: This randomized controlled clinical trial was performed at Benha University Hospital, Benha, Egypt, and included 34 eyes from 34 diabetic patients diagnosed with intractable diffuse diabetic macular edema without vitreomacular traction. The patients were divided into two groups. In group 1, pars plana vitrectomy with removal of the posterior hyaloid was performed, and at the end of the procedure, IVTA 0.1 mL (40 mg/mL) and bevacizumab 1.25 mg were injected. In group 2, macular grid laser photocoagulation was performed 2 weeks after the same intravitreal injection combination as used in group 1. The main outcome measures were best-corrected visual acuity (BCVA) and central foveal thickness, which were measured using optical coherence tomography at 3, 6, and 12 months. RESULTS: Changes in BCVA and central foveal thickness at 3, 6, and 12 months from baseline were highly statistically significant (P < 0.01). Mean BCVA was better in group 1 at 3 months, nearly equal at 6 months, and less at 12 months. Mean central foveal thickness was more improved in group 1 than in group 2 at 3 months, and was better in group 2 at subsequent measurement points. The major adverse events were development of cataract (more common in group 1) and elevation of intraocular pressure (more common in group 2). CONCLUSION: The combined therapy described here could represent a solution for the treatment of intractable diabetic macular edema, and could have a favorable long-term outcome. Combined treatment of IVTA and bevacizumab plus grid laser resulted in a more favorable reduction in central foveal thickness and improvement in BCVA at 12 months than vitrectomy combined with the same injections. This small study favors the safer, cheaper, and more available line of treatment.

Comparative study between trabeculectomy with photodynamic therapy (BCECF-AM) and trabeculectomy with antimetabolite (MMC) in the treatment of primary open angle glaucoma.

BACKGROUND: Various methods have been investigated to avoid postoperative scarring of the filtering bleb in modern glaucoma surgery. Most deal with the application of antimetabolic drugs such as mitomycin C (MMC). 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM) is a locally acting intracellular photosensitizer which could control and decrease postoperative fibrosis at the trabeculectomy site. PURPOSE: To compare the effect of photodynamic therapy in combination with trabeculectomy to the effect of MMC combined with the same procedure in controlling postoperative intraocular pressure (IOP) in patients with medically uncontrolled primary open angle glaucoma (1ry OAG). METHODS: A randomized controlled clinical trial was conducted on 76 eyes of 76 patients divided into three groups undergoing trabeculectomy, trabeculectomy with BCECF-AM (group A), trabeculectomy with MMC (group B), and trabeculectomy only as a control group (group C). Patients were reviewed postoperatively for clinical evaluation and photo documentation of the blebs with a fundus camera and ultrasonic biomicroscopy (UBM). The desirable effect of the adjunctive material was evaluated according to the clinical efficacy, tolerability, and safety by comparison with the control group. SETTING: Benha University Hospital, Benha, Egypt. RESULTS: After a mean follow-up of 24 months, all procedures succeeded in lowering IOP. The cumulative probability of complete success at the 24 month follow-up was 91% for group B, compared to 82% and 81.5% for group A and group C, respectively. The percentage of complete success was highest for group B, second highest for group A, and lowest for group C over the follow-up period; however, these differences were not statistically significant (P > 0.05). Regarding the bleb morphology and UBM reflectivity, the differences were not statistically significant (P > 0.05). The mean bleb height and breadth were larger in groups A and B in comparison to group C over the study period. The mean aqueous drainage route was similar in groups A and C, but less than in group B at 3 and 12 months postoperatively. Complications were generally mild and less marked in group A and C than group B. CONCLUSION: Cellular photoablation using BCECF-AM seems to be a feasible new method to use in combination with glaucoma filtration surgery. Although MMC might be considered a more potent adjunctive to trabeculectomy in promoting IOP reduction, photodynamic therapy carries relatively less risk of adverse effects and complications. Cellular photoablation using BCECF-AM could be considered efficient, tolerable and relatively safer in managing patients with 1ry OAG. Further studies are necessary to determine the safety and the reliability of this therapy.

LASIK as an alternative line to treat noncompliant esotropic children.

PURPOSE: To assess the safety and efficacy of laser-assisted in situ keratomileusis (LASIK) in facilitating strabismus management in noncompliant children with fully accommodative esotropia. SETTING: Ebsar Eye Center, Benha University (Benha, Egypt). METHODS: The study comprised 20 eyes of ten consecutive patients with accommodative esotropia. All patients were noncompliant with glasses and had refractive stability. They received brief general anesthesia and had bilateral LASIK using Wavelight® Algretto Wave® Eye-Q Excimer Laser (Alcon, Inc, Hunenberg, Switzerland) to fully correct their hyperopic refractive errors aiming to achieve orthophoria. Preoperative and postoperative best corrected visual acuity, cycloplegic refraction, angle of squint, and any LASIK complications were recorded. Follow-up period was 9 months. RESULTS: The age of patients ranged 5.1-9.2 years and the hyperopic error range was +3.5 D to +6.75 D, with anisometropia 2 D or less. No patient had decreased best corrected visual acuity or loss of fusion ability. The postoperative refractive error ranged from -0.75 D to +1.5 D at the end of the study period. All patients achieved orthophoria. No significant intraoperative or postoperative complications were recorded. CONCLUSION: LASIK appears to be effective and relatively safe to treat accommodative esotropic children by reducing their hyperopic refractive error, however, patient selection is critical. Larger studies with longer follow-up are necessary to determine its long-term effects.